Study to Evaluate the Efficacy and Safety of PF-06651600 and PF-06700841 to Treat Moderate to Severe Alopecia Areata in Adults

A Phase 2a Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety Profile of PF-06651600 and PF-06700841 in Subjects With Moderate to Severe Alopecia Areata With a Single-Blind Extension Period and a Cross-Over Open Label Extension Period

Category & Conditions:
Immune System Diseases and Conditions
Medicine:
PF-06651600
PF-06700841
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7931005
Open Plain Language Summary Result:Click here